| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,000 | 16.10. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.11. | Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report | ||
| 06.11. | MTNB stock touches 52-week low at $0.5 amid sharp annual decline | ||
| 06.11. | MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar | ||
| 31.10. | Matinas BioPharma mulls wind-down as antifungal therapy deal falls through | ||
| 31.10. | Matinas BioPharma plunges as deal for lead asset falls apart |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.11. | Oruka Therapeutics, Inc. - 8-K, Current Report | ||
| 14.11. | Oruka Therapeutics files to sell 8.72M shares of common stock for holders | ||
| 14.11. | Oruka Therapeutics, Inc. - S-1, General form for registration of securities | ||
| 14.11. | Oruka Therapeutics GAAP EPS of -$1.46 misses by $1.08 | ||
| 13.11. | Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.11. | OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | Leuven, BELGIUM - November 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| 05.11. | OXURION: Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements | Leuven, Belgium - November 5, 2024 - 10:30 AM CET - Oxurion NV (Euronext Brussels: OXUR) announces that it terminated the private judicial reorganization (PRJ) procedure initiated on August 22... ► Artikel lesen | |
| 29.10. | OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition | Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname
LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch... ► Artikel lesen | |
| 24.10. | OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen | |
| 14.10. | OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS INC | 0,572 | 0,00 % |
| ORUKA THERAPEUTICS INC | 20,800 | 0,00 % |
| OXURION NV | 0,271 | +0,93 % |
